Vulvar Vestibulitis: Clinical Trials

2 trials for Vulvar Vestibulitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Vulvar Vestibulitis: new trials by email Literature Review of Vulvar Vestibulitis trials Research Report on Vulvar Vestibulitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study
Classical Acupuncture, Non-classical acupuncture, Lidocaine - Provoked, Localized Vulvodynia, Provoked Vestibulodynia
Phase 1CompletedOregon College of Oriental Medicine192013-11-012017-10-06
Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1391995-06-012025-05-04

Narrower conditions

Chronic Pain (1)  ·  Cystitis, Interstitial (1)  ·  Rare Diseases (1)  ·  Urogenital Diseases (1)  ·  Vulvar Diseases (1)  ·  Vulvodynia (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vulvitis (2)  ·  Cystitis (1)  ·  Disease Attributes (1)  ·  Male Urogenital Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)

Interventions

Capsaicin (1)  ·  Lidocaine (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Oregon College of Oriental Medicine (1)

Countries

United States (2)

Top investigators

Hugh Flood (1)  ·  Lee E Hullender Rubin, DAOM (1)

Results publications

PMID 31592976

NIH funding

R01DK049524 (1)